Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
BMC Pediatrics|August 24, 2016
The problematic use of Information and Communication Technologies (ICT) in adolescents by the cross sectional JOITIC studyRaquel Muñoz-Miralles, Raquel Ortega-González, M Rosa López-Morón, et al.
American Journal of Perinatology|June 15, 2007
Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsisJosé Figueras-Aloy, Lilian Gómez-López, José-Manuel Rodríguez-Miguélez, et al.
Plos One|August 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational ageIan P Keary, Roberto Ravasio, John R Fullarton, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 12, 2016
The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysisXavier Carbonell-Estrany, John R Fullarton, Katherine L Gooch, et al.
The Pediatric Infectious Disease Journal|October 19, 2016
Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus SeasonsEvan J Anderson, Xavier Carbonell-Estrany, Maarten Blanken, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Mortality Risk Factors for Individuals Experiencing Homelessness in Catalonia (Spain): A 10-Year Retrospective Cohort StudyFran Calvo, Oriol Turró-Garriga, Carles Fàbregas, et al.
Pediatric Pulmonology|February 7, 2018
Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infantsMaarten O Blanken, Bosco Paes, Evan J Anderson, et al.
Cost Effectiveness and Resource Allocation : C/E|January 28, 2026
Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infantsCarlos E Rodriguez-Martinez, Jaime Ordonez, Xavier Carbonell-Estrany, et al.
Journal of Perinatal Medicine|September 3, 2010
Ethical dimensions of periviabilityDaniel W Skupski, Frank A Chervenak, Laurence B McCullough, et al.
Open Forum Infectious Diseases|July 28, 2025
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) TaskforcePaolo Manzoni, Eugenio Baraldi, Fabio Midulla, et al.
Pageof 11